About
NerveX is a technology company founded in 2021, dedicated to improving multi-species healthcare through medical device-driven artificial intelligence. Originating from the University of Toronto, NerveX utilizes patented biosensors and digital auscultation technology to track essential biomarkers in animals, primarily pets. Their flagship product, NXVET, employs AI to analyze biomarker data, generate accurate patient records, and provide detailed diagnostic insights and tailored treatment strategies for veterinary use. The company also features the ANIMO (Adaptive Neural Implant for Modulation and Observation), a neural implant aimed at treating canine epilepsy. This implant leverages machine learning and electrical neuromodulation to enhance nervous system function. NerveX's products and services are designed for veterinary clinics and animal healthcare providers, enhancing clinical efficiency by automatically generating medical records and integrating real-time biomarker data. Their innovative solutions support both virtual and in-clinic veterinary care, offering a comprehensive health overview for pets.
Technologies
Keywords
Company Information
-
Employees 6
-
Founded 2020
Location
Toronto, Ontario, Canada
